The last time this had a close above a penny was February 2022. There was only 174 million shares at that time and this same story was fresh then. They commented on the need to register as an Alternative Trading System ("ATS") in the annual filing for 2017. September 2020 they received guidance from the SEC "...to apply for Alternative Trading System ("ATS") status.". Now in September 2023 they can do no better than to say "We intend to continue... and "We currently intend to seek..." when talking about this subject. Statement in the Q3 2023 filing "The completion of our software platform depends on our ability to license it to an existing Alternative Trading System (“ATS”)..." For the fiscal year ended December 31, 2021 https://www.otcmarkets.com/filing/html?id=15694100&guid=yfJ-kFZZ7PzKJth As of March 24, 2022, there were 173,927,698 common shares, $0.001 par value, issued and outstanding.
We understand that we may be required to register as an ATS. Alternatively, we may seek an exemption if we are able to establish a relationship with OTC Market Group to quote our stock on the OTCQB page alongside the Market Makers...
We intend to continue having discussions with various ATS's until we have secured an arrangement that will allow the BDTP™ platform to operate.
We currently intend to seek a contractual arrangement such as a license with an existing ATS for a quoting service, similar to the current listing of our common stock with OTC Markets Group. At this time, no ATS has committed to an arrangement.
We hope that BDTP will be operational, subject to obtaining funding, by 1st Quarter of 2021.
In July 2020, the Company presented the concept to SEC FinHub staff members for regulatory guidance and received the recommendation to apply for Alternative Trading System ("ATS") status. Given that guidance, we are evaluating our options for finalizing the BDTP, including exploring partnerships with existing ATS's. BlackStar will continue to seek further input from various regulatory agencies and OTC Markets on the potential functionality and regulatory aspects of the BDTP over the next several months.